SSY GROUP (02005) has twelve products with fourteen specifications that are expected to win the bid for the eleventh batch of National Group Procurement of Pharmaceuticals.

SSY GROUP (02005) announced that in the 11th batch of national drug centralized procurement bidding in China on October 27, 2025, the group has a total of twelve products and fourteen specifications expected to be awarded: Hydroxypropyl theoteaine injection (2ml:0.3g), Fumarate formoterol inhalation solution (2ml:20g), Fluvoxamine maleate tablets (100mg and 50mg), Clonixin Injection (8mg), Epinephrine hydrochloride injection (1ml:1mg), Bromhexine hydrochloride injection (2ml:4mg), Compound electrolyte injection (500ml), Compound electrolyte injection (II) (500ml and 1000ml), Nicardipine tablets (5mg), Terbutaline sulfate injection (1ml:0.5mg), Benidipine hydrochloride tablets (8mg), and Sodium bicarbonate injection (50ml:4.2g).